Data / Drug companies / Topiderm, Inc.
Topiderm, Inc.: 52 products in the FDA NDC directory, labeler code 51326
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Topiderm, Inc. (labeler code 51326) lists 52 products in the FDA National Drug Code Directory, covering 17 finished drugs by generic name. By type: 52 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on August 12, 2026.
The request: Watch Topiderm, Inc. (FDA labeler code 51326): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 51326
- Products in commercial distribution
- 52
- Packages
- 53
- Finished drugs by generic name
- 17
- Prescription products
- 0
- Over the counter products
- 52
- Flagged as original packager
- 51 of 51 products that carry the flag
- Started marketing in the last 12 months
- 4
- Earliest marketing start
- February 27, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 51 | 98.1% |
| Generic drugs (ANDA) | 1 | 1.9% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 52 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Salicylic acid | 16 | 330 |
| Benzoyl peroxide | 9 | 82 |
| Zinc oxide | 7 | 595 |
| Zinc oxide titanium dioxide | 3 | 4 |
| Zinc oxide and titanium dioxide | 3 | 12 |
| Petrolatum | 2 | 74 |
| Octocrylene, octisalate, zinc oxide | 1 | 4 |
| Pyrithione zinc | 1 | 76 |
| Octinoxate and zinc oxide | 1 | 8 |
| Oatmeal | 1 | 21 |
| Homosalate | 1 | 1 |
| Zinc oxide, octinoxate | 1 | 9 |
| Homosalate, octinoxate, octisalate, avobenzone | 1 | 1 |
| Hydrocortisone | 1 | 171 |
| Minoxidil | 1 | 113 |
| Zinc oxide and octinoxate | 1 | 2 |
| Alcohol | 1 | 293 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Liquid | 18 | 34.6% |
| Lotion | 13 | 25% |
| Cloth | 5 | 9.6% |
| Cream | 4 | 7.7% |
| Gel | 4 | 7.7% |
| Spray | 2 | 3.8% |
| Ointment | 2 | 3.8% |
| Lipstick | 2 | 3.8% |
| Shampoo | 1 | 1.9% |
| Powder | 1 | 1.9% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Non-Standardized Food Allergenic Extract | 1 |
| Non-Standardized Plant Allergenic Extract | 1 |
| Corticosteroid | 1 |
| Arteriolar Vasodilator | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| RFA Purifying Cleanser Clear and Clarify | 51326-502 | Liquid | Over the counter monograph drugs | August 12, 2026 |
| Hello Bello Mineral Sunscreen SPF 50 | 51326-615 | Lotion | Over the counter monograph drugs | July 29, 2026 |
| RFA Clear and Calm Balancing Serum | 51326-133 | Liquid | Over the counter monograph drugs | July 28, 2026 |
| Hello Bello Diaper Rash Cream | 51326-529 | Cream | Over the counter monograph drugs | July 21, 2026 |
| RFA BPO Acne Treatment 2.5% | 51326-176 | Liquid | Over the counter monograph drugs | December 21, 2024 |
| Hybrid SPF SPF 30 | 51326-128 | Spray | Over the counter monograph drugs | October 7, 2024 |
| Topicals Clearly Mist | 51326-307 | Liquid | Over the counter monograph drugs | September 20, 2024 |
| Dr. Zenovia Acne Cleanser | 51326-803 | Liquid | Over the counter monograph drugs | June 11, 2024 |
| Dr. Zenovia Spot Treatment | 51326-802 | Liquid | Over the counter monograph drugs | June 11, 2024 |
| Sheer Mineral Antioxidant Sunscreen SPF50 | 51326-144 | Lotion | Over the counter monograph drugs | April 25, 2024 |
| Dr. Dennis Gross Alpha Beta On the Spot Eliminator | 51326-057 | Gel | Over the counter monograph drugs | November 17, 2023 |
| Dr. Gross AB Acne Daily Breakout | 51326-179 | Liquid | Over the counter monograph drugs | November 10, 2023 |
| Dr. Zenovia Clear Complexion | 51326-801 | Cloth | Over the counter monograph drugs | June 26, 2023 |
| Topix Mineral Mattifying Tinted Sunscreeninted SPF 50 | 51326-370 | Lotion | Over the counter monograph drugs | March 20, 2023 |
| Topix Mineral Mattifying Tinted Sunscreen SPF 50 | 51326-137 | Lotion | Over the counter monograph drugs | November 15, 2022 |
| Mineral Repair SPF 45 | 51326-245 | Lotion | Over the counter monograph drugs | May 7, 2022 |
| Replenix Tinted Sunscreen SPF 50 | 51326-201 | Lotion | Over the counter monograph drugs | April 22, 2022 |
| Blemish Correcting Serum | 51326-940 | Liquid | Over the counter monograph drugs | February 1, 2022 |
| Replenix Lip Therapy homosalate | 51326-102 | Lipstick | Over the counter monograph drugs | January 2, 2022 |
| Clarity Rx Physical Skin Defense SPF 50 | 51326-035 | Lotion | Over the counter monograph drugs | January 1, 2022 |
| Replenix Sunscreen SPF 50 | 51326-220 | Lotion | Over the counter monograph drugs | October 16, 2021 |
| Replenix Gly-Sal 10-2 cleanser | 51326-928 | Liquid | Over the counter monograph drugs | July 26, 2021 |
| Replenix Sheer SPF 50 | 51326-858 | Cream | Over the counter monograph drugs | July 23, 2021 |
| Replenix BP Acne | 51326-841 | Gel | Over the counter monograph drugs | May 13, 2021 |
| Womens Minoxidil Hair Growth System | 51326-161 | Liquid | Generic drugs (ANDA) | March 26, 2021 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.